Myocardial protection for cardiac surgery.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  EXS

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/978-3-0348-8988-9_21PMID 8805805
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy of oxygenated University of Wisconsin solution containing endothelin-A receptor antagonist in twenty-four-hour heart preservation.

  1996cited by this paper
• Sodium-hydrogen exchange inhibitors improve postischemic recovery of function in the perfused rabbit heart.

  1995cited by this paper
• Evidence that donor pretreatment with FK506 has a synergistic effect on graft prolongation in hamster-to-rat heart xenotransplantation.

  1995cited by this paper
• Adenosine pretreatment for prolonged cardiac storage. An evaluation with St. Thomas' Hospital and University of Wisconsin solutions.

  1995cited by this paper
• Intermittent Warm Blood Cardioplegia

  1995cited by this paper
• Myocardial protection for acquired heart disease surgery: results of a national survey.

  1995cited by this paper
• The Registry of the International Society for Heart and Lung Transplantation: twelfth official report--1995.

  1995cited by this paper
• Intermittent warm blood cardioplegia. Warm Heart Investigators.

  1995cited by this paper
• Intermittent antegrade warm versus cold blood cardioplegia: a prospective, randomized study.

  1994cited by this paper
• Warm blood cardioplegic induction: an underused modality.

  1994cited by this paper
• An initial multicenter, randomized controlled trial on the safety and efficacy of acadesine in patients undergoing coronary artery bypass graft surgery. SPI Research Group.

  1994cited by this paper
• Prospective, randomized trial of retrograde warm blood cardioplegia: myocardial benefit and neurologic threat.

  1994cited by this paper
• Cardiac storage with UW solution and glucose.

  1994cited by this paper
• Cardiac allografts from high-risk donors: excellent clinical results.

  1994cited by this paper
• Vitamin E for coronary bypass operations

  1994cited by this paper
• Adenosine in blood cardioplegia prevents postischemic dysfunction in ischemically injured hearts.

  1994cited by this paper
• Prolonging myocardial preservation with a modified University of Wisconsin solution containing 2,3-butanedione monoxime and calcium.

  1994cited by this paper
• Effect of 2,3-butanedione monoxime on myocyte resting force during prolonged metabolic inhibition

  1994cited by this paper
• Nucleoside trapping during reperfusion prevents ventricular dysfunction, "stunning," in absence of adenosine. Possible separation between ischemic and reperfusion injury.

  1994cited by this paper
• The optimal cardioplegic temperature.

  1994cited by this paper
• The role of adenosine in extended myocardial preservation with the University of Wisconsin solution.

  1994cited by this paper
• Vitamin E for coronary bypass operations. A prospective, double-blind, randomized trial.

  1994cited by this paper
• Cardiopulmonary bypass, temperature, and central nervous system dysfunction.

  1994cited by this paper
• Myocardial Glucose Uptake in Patients With Insulin‐Dependent Diabetes Mellitus Assessed Quantitatively by Dynamic Positron Emission Tomography

  1993cited by this paper
• Elective cardiac arrest with a hyperpolarizing adenosine triphosphate-sensitive potassium channel opener. A novel form of myocardial protection?

  1993cited by this paper
• Ventricular function after normothermic versus hypothermic cardioplegia.

  1993cited by this paper
• University of Wisconsin versus St. Thomas' Hospital solution for human donor heart preservation.

  1993cited by this paper
• Novel Preservation Solution Permits 24‐Hour Preservation in Rat and Baboon Cardiac Transplant Models

  1993cited by this paper
• Novel preservation solution permits 24-hour preservation in rat and baboon cardiac transplant models.

  1993cited by this paper
• Superiority of controlled surgical reperfusion versus percutaneous transluminal coronary angioplasty in acute coronary occlusion.

  1993cited by this paper
• Retrograde versus antegrade delivery of cardioplegic solution in myocardial revascularization. A clinical trial in patients with three-vessel coronary artery disease who underwent myocardial revascularization with extensive use of the internal mammary artery.

  1993cited by this paper
• Effects of University of Wisconsin solution on endothelium-dependent coronary artery relaxation in the rat.

  1993cited by this paper
• Detrimental effects of interrupting warm blood cardioplegia during coronary revascularization.

  1993cited by this paper
• Coronary Endothelial Injury After Cardiopulmonary Bypass and Ischemic Cardioplegia Is Mediated by Oxygen‐Derived Free Radicals

  1993cited by this paper
• Should adenosine continue to be ignored as a cardioprotective agent in cardiac operations?

  1993cited by this paper
• Acadesine: the prototype adenosine regulating agent for reducing myocardial ischaemic injury.

  1993cited by this paper
• Acadesine Improves Surgical Myocardial Protection With Blood Cardioplegia in Ischemically Injured Canine Hearts

  1993cited by this paper
• Effect of 2,3-butanedione monoxime on myocyte resting force during prolonged metabolic inhibition.

  1992cited by this paper
• Regular Physical Exercise and Low‐Fat Diet: Effects on Progression of Coronary Artery Disease

  1992cited by this paper
• Optimal delivery of cardioplegic solution for "redo" operations.

  1992cited by this paper
• Improved myocardial ischemic tolerance by contractile inhibition with 2,3-butanedione monoxime.

  1992cited by this paper
• Sustained Protection by Acadesine Against Ischemia‐ and Reperfusion‐Induced Injury: Studies in the Transplanted Rat Heart

  1992cited by this paper
• Endothelial dysfunction caused by University of Wisconsin preservation solution in the rat heart. The importance of temperature.

  1992cited by this paper
• Activated neutrophils impair rabbit heart recovery after hypothermic global ischemia.

  1992cited by this paper
• Effects of nucleoside transport inhibition on long-term ex vivo preservation of canine hearts.

  1992cited by this paper
• Leukocyte-depleted reperfusion of transplanted human hearts: a randomized, double-blind clinical trial.

  1992cited by this paper
• Warm heart surgery.

  1992cited by this paper
• University of Wisconsin solution versus crystalloid cardioplegia for human donor heart preservation. A randomized blinded prospective clinical trial.

  1992cited by this paper
• Protective Effects of Adenosine In Myocardial Ischemia

  1992cited by this paper
• Retrograde cardioplegia: current methods.

  1992cited by this paper
• Acadesine (AICA-riboside) improves postischemic cardiac recovery.

  1992cited by this paper
• LIMITATIONS OF HEART PRESERVATION BY COLD STORAGE

  1992cited by this paper
• Controlled reperfusion of the regionally ischemic myocardium with leukocyte-depleted blood reduces stunning, the no-reflow phenomenon, and infarct size.

  1992cited by this paper
• Blood cardioplegia: a review and comparison with crystalloid cardioplegia.

  1991cited by this paper
• Retrograde continuous warm blood cardioplegia: a new concept in myocardial protection.

  1991cited by this paper
• Twelve-hour cardiopulmonary preservation using donor core cooling, leukocyte depletion, and liposomal superoxide dismutase.

  1991cited by this paper
• Studies of controlled reperfusion after ischemia. XXI. Reperfusate composition: superiority of blood cardioplegia over crystalloid cardioplegia in limiting reperfusion damage--importance of endogenous oxygen free radical scavengers in red blood cells.

  1991cited by this paper
• A randomized controlled trial of allopurinol in coronary bypass surgery.

  1991cited by this paper
• Role of potassium concentration in cardioplegic solutions in mediating endothelial damage.

  1991cited by this paper
• Warm heart surgery and results of operation for recent myocardial infarction.

  1991cited by this paper
• Complete functional recovery after 24-hour heart preservation with University of Wisconsin solution and modified reperfusion.

  1991cited by this paper
• Prolonged hypothermic cardiac storage with University of Wisconsin solution. An assessment with human cell cultures.

  1991cited by this paper
• Cardiac preservation in patients undergoing transplantation. A clinical trial comparing University of Wisconsin solution and Stanford solution.

  1991cited by this paper
• Augmenting intracellular adenosine improves myocardial recovery.

  1990cited by this paper
• Retrograde coronary sinus cardioplegia for aortic valve operations: a clinical report on 500 patients.

  1990cited by this paper
• Influence of human leukocyte antigen matching in cardiac transplantation.

  1990cited by this paper
• Adenosine cardioplegia. Adenosine versus potassium cardioplegia: effects on cardiac arrest and postischemic recovery in the isolated rat heart.

  1989cited by this paper
• Prevention of reperfusion injury in the neonatal heart with leukocyte-depleted blood.

  1989cited by this paper
• Myocardial salvage with trolox and ascorbic acid for an acute evolving infarction.

  1989cited by this paper
• Principles of solid-organ preservation by cold storage.

  1988cited by this paper
• Intraoperative myocardial protection in the context of coronary revascularization.

  1987cited by this paper
• Role of Changes in [Ca2+]i in Energy Deprivation Contracture

  1987cited by this paper
• Strategies and logic of cardioplegic delivery to prevent, avoid, and reverse ischemic and reperfusion damage.

  1987cited by this paper
• Accelerated myocardial metabolic recovery with terminal warm blood cardioplegia.

  1986cited by this paper
• Immediate functional recovery after six hours of regional ischemia by careful control of conditions of reperfusion and composition of reperfusate.

  1986cited by this paper
• Studies of controlled reperfusion after ischemia.

  1986cited by this paper
• Safety of prolonged aortic clamping with blood cardioplegia. III. Aspartate enrichment of glutamate-blood cardioplegia in energy-depleted hearts after ischemic and reperfusion injury.

  1984cited by this paper
• Warm induction of cardioplegia with glutamate-enriched blood in coronary patients with cardiogenic shock who are dependent on inotropic drugs and intra-aortic balloon support.

  1983cited by this paper
• Benefits of normothermic induction of blood cardioplegia in energy-depleted hearts, with maintenance of arrest by multidose cold blood cardioplegic infusions.

  1982cited by this paper
• The Stunned Myocardium: Prolonged, Postischemic Ventricular Dysfunction

  1982cited by this paper
• The "wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow.

  1979cited by this paper
• Respiratory and Circulatory Studies of Patients with Mitral Stenosis

  1953cited by this paper

• Trends in cardiac surgery: exploring the past and looking into the future.

  2007cites this paper
• NHE-1 Inhibitors: Potential Application in Cardiac Surgery

  2003cites this paper
• Intraoperative metabolic monitoring of the heart: I. Clinical assessment of coronary sinus metabolites.

  2001cites this paper
• Redox-Mediated Gene Therapies for Environmental Injury: Approaches and Concepts

  1999cites this paper